Stay updated on VS-6766 and Everolimus Clinical Trial
Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.

Latest updates to the VS-6766 and Everolimus Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag on the page was updated from v3.6.2 to v3.6.3. This reflects a minor platform update and does not alter the displayed study details.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates an updated release of the page's content or metadata.SummaryDifference0.0%

- Check31 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating that enrollment has ended. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated to reflect formatting changes on the study details page.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This represents a minor internal version update with no apparent changes to content or functionality.SummaryDifference0.0%

- Check60 days agoChange DetectedThe Publications section now references the Guo et al. Lancet Oncology 2020 article as the original publication and removes the Erratum entry; version notes indicate an addition (v3.5.4) and a corresponding deletion (v3.5.3).SummaryDifference0.1%

- Check82 days agoChange DetectedThe page metadata revision/version number has been incremented from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.